Global Clinical Trial Imaging Market Report, History and Forecast 2018-2029
Description
Global Clinical Trial Imaging Market Report, History and Forecast 2018-2029
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Clinical Trial Imaging estimated was at US$ 1,373.38 million in the year 2022, is projected to reach a revised size of US$ 2,208.53 million by 2029, growing at a CAGR of 6.93% during the forecast period 2023-2029.
North American market for Clinical Trial Imaging was valued at $ 462.00 million in 2022 and will reach $ 712.74 million by 2029, at a CAGR of 6.30% during the forecast period of 2023 through 2029.
Asia-Pacific market for Clinical Trial Imaging was valued at $ 375.08 million in 2022 and will reach $ 645.11 million by 2029, at a CAGR of 7.95% during the forecast period of 2023 through 2029.
Europe market for Clinical Trial Imaging was valued at $ 372.89 million in 2022 and will reach $ 591.65 million by 2029, at a CAGR of 6.69% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging.
The Clinical Trial Imaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Clinical Trial Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Clinical Trial Imaging segments by company, by Type, by Application, by region and country, and provides market size and CAGR for the history and forecast period (2018-2023, 2024-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
Clario
ICON
McLaren
Calyx
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Segment by Type
In-house Imaging Service
Central Imaging Service
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
India
Southeast Asia
Korea
Australia
Others
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Others
South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
South Africa
Turkey
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Clinical Trial Imaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Clinical Trial Imaging estimated was at US$ 1,373.38 million in the year 2022, is projected to reach a revised size of US$ 2,208.53 million by 2029, growing at a CAGR of 6.93% during the forecast period 2023-2029.
North American market for Clinical Trial Imaging was valued at $ 462.00 million in 2022 and will reach $ 712.74 million by 2029, at a CAGR of 6.30% during the forecast period of 2023 through 2029.
Asia-Pacific market for Clinical Trial Imaging was valued at $ 375.08 million in 2022 and will reach $ 645.11 million by 2029, at a CAGR of 7.95% during the forecast period of 2023 through 2029.
Europe market for Clinical Trial Imaging was valued at $ 372.89 million in 2022 and will reach $ 591.65 million by 2029, at a CAGR of 6.69% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging.
The Clinical Trial Imaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Clinical Trial Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Clinical Trial Imaging segments by company, by Type, by Application, by region and country, and provides market size and CAGR for the history and forecast period (2018-2023, 2024-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
Clario
ICON
McLaren
Calyx
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Segment by Type
In-house Imaging Service
Central Imaging Service
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
India
Southeast Asia
Korea
Australia
Others
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Others
South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
South Africa
Turkey
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Clinical Trial Imaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Table of Contents
115 Pages
- 1 Market Overview Of Clinical Trial Imaging
- 1.1 Clinical Trial Imaging Market Overview
- 1.1.1 Clinical Trial Imaging Product Scope
- 1.1.2 Clinical Trial Imaging Market Status And Outlook
- 1.2 Global Clinical Trial Imaging Market Size Overview By Region 2018 Vs 2022 Vs 2029
- 1.3 Global Clinical Trial Imaging Market Size By Region (2018-2029)
- 1.4 Global Clinical Trial Imaging Historic Market Size By Region (2018-2023)
- 1.5 Global Clinical Trial Imaging Market Size Forecast By Region (2024-2029)
- 1.6 Key Regions Clinical Trial Imaging Market Size (2018-2029)
- 1.6.1 North America Clinical Trial Imaging Market Size (2018-2029)
- 1.6.2 Europe Clinical Trial Imaging Market Size (2018-2029)
- 1.6.3 Asia-pacific Clinical Trial Imaging Market Size (2018-2029)
- 1.6.4 South America Clinical Trial Imaging Market Size (2018-2029)
- 1.6.5 Middle East & Africa Clinical Trial Imaging Market Size (2018-2029)
- 2 Clinical Trial Imaging Market Overview By Type
- 2.1 Global Clinical Trial Imaging Market Size By Type: 2018 Vs 2022 Vs 2029
- 2.2 Global Clinical Trial Imaging Historic Market Size By Type (2018-2023)
- 2.3 Global Clinical Trial Imaging Forecasted Market Size By Type (2024-2029)
- 2.4 In-house Imaging Service
- 2.5 Central Imaging Service
- 3 Clinical Trial Imaging Market Overview By Application
- 3.1 Global Clinical Trial Imaging Market Size By Application: 2018 Vs 2022 Vs 2029
- 3.2 Global Clinical Trial Imaging Historic Market Size By Application (2018-2023)
- 3.3 Global Clinical Trial Imaging Forecasted Market Size By Application (2024-2029)
- 3.4 Pharmaceutical Companies
- 3.5 Biotechnology Companies
- 3.6 Academic Institutes
- 3.7 Others
- 4 Clinical Trial Imaging Competition Analysis By Players
- 4.1 Global Clinical Trial Imaging Market Size By Players (2018-2023)
- 4.2 Global Top Players By Company Type (Tier 1, Tier 2, And Tier 3) & (Based On The Revenue In Clinical Trial Imaging As Of 2022)
- 4.3 Global Key Players Of Clinical Trial Imaging Head Office And Area Served
- 4.4 Global Key Players Of Clinical Trial Imaging, Established Date
- 4.5 Competitive Status
- 4.5.1 Clinical Trial Imaging Market Concentration Rate
- 4.5.2 Mergers & Acquisitions, Expansion Plans
- 5 Company (Top Players) Profiles
- 5.1 Clario
- 5.1.1 Clario Company Details
- 5.1.2 Clario Main Business Overview
- 5.1.3 Clario Clinical Trial Imaging Introduction
- 5.1.4 Clario Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.1.5 Clario Recent Development
- 5.2 Icon
- 5.2.1 Icon Company Details
- 5.2.2 Icon Main Business Overview
- 5.2.3 Icon Clinical Trial Imaging Introduction
- 5.2.4 Icon Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.2.5 Icon Recent Development
- 5.3 Mclaren
- 5.3.1 Mclaren Company Details
- 5.3.2 Mclaren Main Business Overview
- 5.3.3 Mclaren Clinical Trial Imaging Introduction
- 5.3.4 Mclaren Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.3.5 Mclaren Recent Development
- 5.4 Calyx
- 5.4.1 Calyx Company Details
- 5.4.2 Calyx Main Business Overview
- 5.4.3 Calyx Clinical Trial Imaging Introduction
- 5.4.4 Calyx Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.4.5 Calyx Recent Development
- 5.5 Biotelemetry
- 5.5.1 Biotelemetry Company Details
- 5.5.2 Biotelemetry Main Business Overview
- 5.5.3 Biotelemetry Clinical Trial Imaging Introduction
- 5.5.4 Biotelemetry Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.5.5 Biotelemetry Recent Development
- 5.6 Proscan Imaging
- 5.6.1 Proscan Imaging Company Details
- 5.6.2 Proscan Imaging Main Business Overview
- 5.6.3 Proscan Imaging Clinical Trial Imaging Introduction
- 5.6.4 Proscan Imaging Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.6.5 Proscan Imaging Recent Development
- 5.7 Imaging Endpoints
- 5.7.1 Imaging Endpoints Company Details
- 5.7.2 Imaging Endpoints Main Business Overview
- 5.7.3 Imaging Endpoints Clinical Trial Imaging Introduction
- 5.7.4 Imaging Endpoints Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.7.5 Imaging Endpoints Recent Development
- 5.8 Radiant Sage
- 5.8.1 Radiant Sage Company Details
- 5.8.2 Radiant Sage Main Business Overview
- 5.8.3 Radiant Sage Clinical Trial Imaging Introduction
- 5.8.4 Radiant Sage Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.9 Micron, Inc.
- 5.9.1 Micron, Inc. Company Details
- 5.9.2 Micron, Inc. Main Business Overview
- 5.9.3 Micron, Inc. Clinical Trial Imaging Introduction
- 5.9.4 Micron, Inc. Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.9.5 Micron, Inc. Recent Development
- 5.10 Intrinsic Imaging
- 5.10.1 Intrinsic Imaging Company Details
- 5.10.2 Intrinsic Imaging Main Business Overview
- 5.10.3 Intrinsic Imaging Clinical Trial Imaging Introduction
- 5.10.4 Intrinsic Imaging Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.10.5 Intrinsic Imaging Recent Development
- 5.11 Median Technologies
- 5.11.1 Median Technologies Company Details
- 5.11.2 Median Technologies Main Business Overview
- 5.11.3 Median Technologies Clinical Trial Imaging Introduction
- 5.11.4 Median Technologies Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.11.5 Median Technologies Recent Development
- 5.12 Cardiovascular Imaging Technologies
- 5.12.1 Cardiovascular Imaging Technologies Company Details
- 5.12.2 Cardiovascular Imaging Technologies Main Business Overview
- 5.12.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Introduction
- 5.12.4 Cardiovascular Imaging Technologies Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.13 Banook Medical
- 5.13.1 Banook Medical Company Details
- 5.13.2 Banook Medical Main Business Overview
- 5.13.3 Banook Medical Clinical Trial Imaging Introduction
- 5.13.4 Banook Medical Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.13.5 Banook Medical Recent Development
- 5.14 Ixico
- 5.14.1 Ixico Company Details
- 5.14.2 Ixico Main Business Overview
- 5.14.3 Ixico Clinical Trial Imaging Introduction
- 5.14.4 Ixico Revenue In Clinical Trial Imaging Business (2018-2023)
- 5.14.5 Ixico Recent Development
- 6 North America
- 6.1 North America Clinical Trial Imaging Market Size By Country (2018-2029)
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
- 7 Europe
- 7.1 Europe Clinical Trial Imaging Market Size By Country (2018-2029)
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic Countries
- 7.8 Rest Of Europe
- 8 Asia-pacific
- 8.1 Asia-pacific Clinical Trial Imaging Market Size By Region (2018-2029)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest Of Asia-pacific
- 9 South America
- 9.1 South America Clinical Trial Imaging Market Size By Country (2018-2029)
- 9.2 Brazil
- 9.3 Rest Of South America
- 10 Middle East & Africa
- 10.1 Middle East & Africa Clinical Trial Imaging Market Size By Country
- 10.2 Turkey
- 10.3 Gcc Countries
- 10.4 South Africa
- 10.5 Rest Of Middle East & Africa
- 11 Clinical Trial Imaging Market Dynamics
- 11.1 Clinical Trial Imaging Industry Trends
- 11.2 Clinical Trial Imaging Market Drivers
- 11.3 Clinical Trial Imaging Market Challenges
- 11.4 Porter’s Five Forces Analysis
- 12 Research Finding/Conclusion
- 13 Methodology And Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown And Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
- 13.4 Disclaimer
- List Of Tables
- Table 1. Global Market Clinical Trial Imaging Market Size (Us$ Million) Comparison By Region: 2018 Vs 2022 Vs 2029
- Table 2. Global Clinical Trial Imaging Market Size By Region (2018-2023) & (Us$ Million)
- Table 3. Global Clinical Trial Imaging Market Size Share By Region (2018-2023)
- Table 4. Global Clinical Trial Imaging Forecasted Market Size By Region (2024-2029) & (Us$ Million)
- Table 5. Global Clinical Trial Imaging Forecasted Market Size Share By Region (2024-2029)
- Table 6. Global Clinical Trial Imaging Market Size (Us$ Million) By Type: 2018 Vs 2022 Vs 2029
- Table 7. Global Clinical Trial Imaging Market Size By Type (2018-2023) & (Us$ Million)
- Table 8. Global Clinical Trial Imaging Revenue Market Share By Type (2018-2023)
- Table 9. Global Clinical Trial Imaging Forecasted Market Size By Type (2024-2029) & (Us$ Million)
- Table 10. Global Clinical Trial Imaging Revenue Market Share By Type (2024-2029)
- Table 11. Global Clinical Trial Imaging Market Size By Application: (Us$ Million) 2018 Vs 2022 Vs 2029
- Table 12. Global Clinical Trial Imaging Market Size By Application (2018-2023) & (Us$ Million)
- Table 13. Global Clinical Trial Imaging Revenue Market Share By Application (2018-2023)
- Table 14. Global Clinical Trial Imaging Forecasted Market Size By Application (2024-2029) & (Us$ Million)
- Table 15. Global Clinical Trial Imaging Revenue Market Share By Application (2024-2029)
- Table 16. Global Clinical Trial Imaging Revenue By Players (2018-2023) & (Us$ Million)
- Table 17. Global Clinical Trial Imaging Revenue Market Share By Players (2018-2023)
- Table 18. Global Top Players Market Share By Company Type (Tier 1, Tier 2, And Tier 3) & (Based On The Revenue In Clinical Trial Imaging As Of 2022)
- Table 19. Global Key Players Of Clinical Trial Imaging, Headquarters And Area Served
- Table 20. Global Key Players Of Clinical Trial Imaging, Established Date
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
